Pentamidine is a medication used in the management and treatment of Pneumocystis pneumonia, leishmaniasis, and trypanosomiasis. It is in the anti-infective (fungal/protozoal) class of drugs. This activity outlines the indications, action, and contraindications for pentamidine as a valuable agent in the treatment and prophylaxis of Pneumocystis pneumonia, leishmaniasis, and trypanosomiasis. This activity will highlight the mechanism of action, adverse event profile, and other key factors (e.g., off-label uses, dosing, pharmacodynamics, pharmacokinetics, monitoring, relevant interactions) pertinent for members of the healthcare team in the treatment of patients with Pneumocystis pneumonia, leishmaniasis, and trypanosomiasis, and related conditions.

**Objectives:**
- Identify the mechanism of action of pentamidine.
- Describe the potential adverse effects of pentamidine.
- Review the appropriate monitoring for patients receiving pentamidine.
- Outline interprofessional team strategies for improving care coordination and communication to advance patients care and improve outcomes when using pentamidine.